Women's Health

The women’s health channel includes news, videos, podcasts and other content related to technology used to detect and treat breast cancer and cervical cancer, including mammography, breast magnetic resonance imaging (MRI), automated breast ultrasound (ABUS), breast ultrasound, breast biopsy and breast radiation therapy.

A triple-negative breast cancer cell during cell division. Tubulin in red; mitochondria in green; chromosomes in blue. Image courtesy of Wei Qian, National Cancer Institute
News | Breast Imaging
Pandemic Upends Breast Cancer Diagnoses

February 16, 2022 — The COVID-19 pandemic upended many aspects of daily life, particularly in the first months and year ...

Time February 16, 2022
arrow
Key findings from research on out-of-pocket costs borne by patients who have an abnormal result on a cancer screening that is free under the Affordable Care Act. Image courtesy of the University of Michigan
News | Radiology Imaging
Follow-up Costs Can Add Up if a Free Cancer Screening Shows a Potential Problem

February 15, 2022 — With the White House putting cancer prevention and early treatment squarely in the sights of its ...

Time February 15, 2022
arrow
The American College of Radiology (ACR) reports that several states are considering breast, colon and lung cancer screening measures.
News | Radiology Imaging
States Advance Cancer Screening, Prior Authorization and Scope of Practice Legislation

The American College of Radiology (ACR) reports that several states are considering breast, colon and lung cancer ...

Time February 14, 2022
arrow
(A) A 46-year-old patient with a strong family history of breast cancer had a screening ultrasound prior to COVID-19 vaccination demonstrating a morphologically normal left axillary lymph node. (B) 25 days following the second dose of the COVID-19 vaccination, the patient presented with a palpable lump in the left axilla and ultrasound demonstrated enlarged lymph nodes with cortex measuring up to 6 mm in thickness (arrow). (C) A follow-up ultrasound 21 weeks following demonstrated stable axillary lymphadeno
News | Breast Imaging
No Need to Delay Mammogram after COVID Vaccine

February 8, 2022 — There should be no delay in screening mammograms after COVID-19 vaccination due to a swelling in the ...

Time February 08, 2022
arrow
The study published as the front-page cover paper of the January issue of IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.​​​​​​​ Image courtesy of POSTECH
News | Point-of-Care Ultrasound (POCUS)
Combining Two Different Ultrasounds for Accurate Breast Cancer Detection

February 4, 2022 — A new diagnostic tool for breast cancer that combines two ultrasounds has been developed. A POSTECH ...

Time February 04, 2022
arrow
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced today the details of its first national, direct-to-consumer advertising campaign. The campaign will launch with a 30-second spot on NBC during the “Big Game” on February 13, 2022, and run through the Winter Olympics across NBCU television and digital channels.
News | Women's Health
Hologic Launches First-ever National Advertising Campaign Featuring Mary J. Blige

February 3, 2022 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...

Time February 03, 2022
arrow
49-Year-Old Woman Presenting for Screening Mammography, Revealing Right Breast Architectural Distortion: (A) Right craniocaudal, (B) mediolateral oblique, (C) spot compression tomosynthesis images show architectural distortion in right breast at 12 o’clock position (arrows). No sonographic correlate identified. Tomosynthesis-guided needle biopsy yielded radial scar—not upgraded at surgery.
News | Breast Imaging
Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology

February 3, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), imaging surveillance is a ...

Time February 03, 2022
arrow
Urgent and immediate action must be taken to ensure more effective and equitable implementation of cancer screening, according to a report released today by the President's Cancer Panel.
News | Radiology Imaging
President's Cancer Panel Calls for Urgent Action to Address Gaps in Cancer Screening Uptake

February 2, 2022 — Urgent and immediate action must be taken to ensure more effective and equitable implementation of ...

Time February 02, 2022
arrow
Before TIL therapy, a woman with breast cancer had metastatic lesions in her chest wall (top, left) and liver (bottom, left). After receiving the immunotherapy, her tumors shrank completely, and recent scans (right) show that she remains cancer free more than five years later.National Cancer Institute
News | Breast Imaging
NIH Study Advances Personalized Immunotherapy for Metastatic Breast Cancer

February 1, 2022 — An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could ...

Time February 01, 2022
arrow
The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period.
News | Breast Imaging
Insights on the Mammography Devices Global Market to 2026

January 31, 2022 — The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at ...

Time January 31, 2022
arrow
The world market for breast imaging equipment is forecast to reach almost $1.3 billion by 2024, and the breast imaging artificial intelligence (AI) market is forecast to reach $205 million, according to a new report from Signify Research.
Feature | Breast Imaging | By Bhvita Jani
Global Drivers of the Breast Imaging Market

The rising global incidence rates of breast cancer, coupled with the severe backlog of women requiring breast cancer ...

Time January 20, 2022
arrow
Today, as part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the health of all women, the Center for Devices and Radiological Health (CDRH) is sharing its Health of Women Program Strategic Plan. CDRH initially issued a proposed strategic plan in September 2019 and has considered public feedback to inform this strategic plan, which lays out the framework to further the FDA’s mission by protecting and promoting the health of women, strengthening regulatory science, and
News | Women's Health
FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation

January 18, 2022 — The following statement was issued today by the U.S. Food and Drug Administration (FDA), and is ...

Time January 18, 2022
arrow
UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market.
News | Breast Imaging
UE LifeSciences and Siemens Healthineers Launch iBreastExam in the U.S.

January 18, 2022 — UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers ...

Time January 18, 2022
arrow
57-Year-Old Woman Presented for Screening Mammography: Digital, A, and tomosynthesis, B, craniocaudal images showed 1.8 cm asymmetry (arrows) lateral left breast categorized as BI-RADS 0. C, Ultrasound left breast evaluation revealed normal fibroglandular tissue (arrow) believed to correlate with mammographic finding. D, Asymmetry effaced on rolled lateral craniocaudal imaging. Metallic BB marker noted at 12 o’clock position, anterior depth. Final assessment BI-RADS 1. Image courtesy of ARRS
News | Ultrasound Women's Health
Recalled Noncalcified Lesions: Ultrasound vs. Ultrasound Plus Mammography

January 17, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), radiologists should ...

Time January 17, 2022
arrow
Most AI for spotting pre-cancerous lesions in mammography scans don’t reveal any of their decision-making process (top). If they do, it’s often a saliency map (middle) that only tells doctors where they’re looking. A new AI platform (bottom) not only tells doctors where it’s looking, but which past experiences its using to draw its conclusions.
News | Mammography
The First AI Breast Cancer Sleuth That Shows Its Work

January 14, 2022 — Computer engineers and radiologists at Duke University have developed an artificial intelligence ...

Time January 14, 2022
arrow
Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base.
News | Mammography
Infinitt announces Partnership with Lunit

January 13, 2022 — Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare ...

Time January 13, 2022
arrow
Less-experienced radiologists are more likely to recommend additional imaging for women undergoing breast cancer screening when they read digital breast tomosynthesis (DBT) images later in the day, according to a new study in Radiology.
News | Breast Imaging
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs

January 11, 2022 — Less-experienced radiologists are more likely to recommend additional imaging for women undergoing ...

Time January 11, 2022
arrow
Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak report on industry leaders in diagnostic imaging equipment in the United States.
News | Radiation Oncology
Varian and Siemens Healthineers Recognized in Survey of U.S. Radiation Oncology and Diagnostic Imaging Professionals

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

Time January 07, 2022
arrow
The AI software is integrated into Gestalt Diagnostics's PathFlow platform for streamlined access and workflow for BioReference's pathologists and external pathology customers. This makes BreastIHC the first AI-based product in pathology to be used in routine clinical practice in the United States.
News | Digital Pathology
Gestalt Diagnostics and MindPeak Provide the First Artificial Intelligence Based Diagnostics Solution Used in Clinical Routine Pathology in the USA

January 5, 2022 — Hamburg, Germany, based Mindpeak and Spokane, Wash., based Gestalt Diagnostics have achieved a major ...

Time January 05, 2022
arrow
Videos | Breast Imaging
VIDEO: Mammography Trends and Advances at RSNA 2021

Stamatia Destounis, M.D., FACR, chief of the American College of Radiology (ACR) Breast Commission, managing partner ...

Time December 13, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now